Medicine and Dentistry
Prospective Cohort Study
100%
Rheumatic Disease
100%
Humoral Immunity
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Disease-Modifying Antirheumatic Drug
42%
Outpatient
28%
Immune Response
28%
Psoriatic Arthritis
28%
Antibody Response
28%
Booster Dose
28%
Spondyloarthropathy
28%
COVID-19 Vaccine
28%
Inflammatory Arthritis
28%
Diseases
28%
Population Research
14%
COVID-19
14%
Disease Activity
14%
Combination Therapy
14%
Immunoglobulin G
14%
Rheumatoid Arthritis
14%
Immunoassay
14%
Musculoskeletal Disease
14%
Patient-Reported Outcome
14%
Outcome Assessment
14%
COVID-19 Vaccination
14%
Messenger RNA
14%
Vaccine Efficacy
14%
Nursing and Health Professions
Rheumatic Disease
100%
Prospective Cohort Study
100%
Severe Acute Respiratory Syndrome
100%
Autoimmune Disease Immunofluorescence Assay Kit
50%
Health Care Personnel
20%
Outpatient
20%
Psoriatic Arthritis
20%
Spondyloarthropathy
20%
Booster Dose
20%
Inflammatory Arthritis
20%
Diseases
20%
Confidence Interval
10%
Health Care Policy
10%
Disease Activity
10%
Rheumatoid Arthritis
10%
Combination Therapy
10%
Musculoskeletal Disease
10%
Patient-Reported Outcome
10%
Outcome Assessment
10%
Vaccine Efficacy
10%
Immunoassay
10%
Immunoglobulin G
10%
Pandemic
10%
BNT162b2 vaccine
10%
Messenger RNA
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Cohort Study
100%
SARS Coronavirus
100%
Rheumatic Disease
100%
Psoriatic Arthritis
25%
Spondyloarthropathy
25%
COVID-19 Vaccine
25%
Inflammatory Arthritis
25%
Diseases
25%
Population Study
12%
Immunoglobulin G
12%
Combination Therapy
12%
Rheumatoid Arthritis
12%
Disease Activity
12%
Musculoskeletal Disease
12%
Pandemic
12%
Messenger RNA
12%
Vaccine Efficacy
12%
Immunology and Microbiology
Rheumatic Disease
100%
Humoral Immunity
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Inflammatory Arthritis
20%
Psoriatic Arthritis
20%
Immune Response
20%
Antibody Response
20%
Booster Dose
20%
Vaccine Efficacy
10%
Population Research
10%
Immunoglobulin G
10%
COVID-19
10%